logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Minji K. Lee

Mayo Clinic
H指数:15
被引数:645

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical Outcomes of Minibeam Radiotherapy for Superficial Skin and Soft Tissue Malignancies

微束放射疗法治疗浅表皮肤和软组织恶性肿瘤的临床疗效

International Journal of Radiation Oncology Biology Physics
IF6.5
2026-08-140
OAAI
Kiran K. Chauhan; Michael P. Grams; Minji K. Lee; Sean S. Park; Anne W. Rajkumar; Darwin A. Garcia; Jonathan M. Morris; Chrystian Quintero Mateus; Arkadiusz Z. Dudek; Rachael M. Guenzel; Lisa A. Kottschade; Nadia N. Laack; Kimberly S. Corbin; Bradley J. Stish; Scott C. Lester; Robert W. Mutter
Real-World Evidence of Disproportionate Financial Toxicity and Health-Related Social Needs Among Adolescents and Young Adults Receiving Care at an NCI-Designated Cancer Center

NCI指定癌症中心中青少年和年轻人在接受护理时出现不成比例的经济毒性及与健康相关的社会需求的真实世界证据

Current Oncology
IF3.4
2026-08-130
OA
Brittany C. Kimball; Minji K. Lee; Kimberly O. Steinert; Jordan A. Mason; Wendy A. Hanson; Wendy A. Allen-Rhoades; Allison C. Rosenthal; Nandita Khera; Robert R. McWilliams
Pembrolizumab with or without chemotherapy among older adults with advanced lung adenocarcinoma: a national, nonrandomized open-label phase II trial (Alliance A171901)

帕博利珠单抗联合或不联合化疗治疗老年晚期肺腺癌：一项全国性、非随机开放标签II期试验（Alliance A171901）

JNCI: Journal of the National Cancer Institute
IF0
2026-05-200
PRE
Melisa L Wong, MD, MAS; Minji K Lee, PhD; Oudom Kour, MS; Daniel Satele; Carolyn J Presley, MD, MHS; Jennifer Le-Rademacher, PhD; Michael Ojelabi, MD; Selina Chow, MD; Thomas E Stinchcombe, MD; Sherri Homan, PhD, RN; Heidi D Finnes, PharmD, BCOP; Saiama Waqar, MD; Aminah Jatoi, MD
Placebo Response in Phase II-III Symptom Intervention Studies: A Focus on Chemotherapy-Induced Peripheral Neuropathy and Associated Neuropathic Pain

II-III期症状干预研究中的安慰剂反应：聚焦于化疗诱导的周围神经病变及相关神经病理性疼痛

Cancers
IF4.4
2026-05-080
OAAI
David Zahrieh; Daniel Satele; Hiboombe Haamankuli; Xin Shelley Wang; Jennifer G. Le-Rademacher; Minji Lee; Heshan Liu; Julian Diaz-Cobo; Shu-En Shen; Selina Chow; Maryam Lustberg; Kathryn J. Ruddy; Ellen M. Lavoie Smith
ProAE: an R package for graphical tools and standardized analysis of patient-reported outcomes and adverse events data

ProAE：一个用于患者报告结局和不良事件数据图形工具与标准化分析的R软件包

BMC Medical Informatics and Decision Making
IF3.8
2025-12-200
OAAI
Blake Langlais; Brie Noble; Briant Fruth; Mia Truman; Gina L. Mazza; Brenda Ginos; Carolyn Mead-Harvey; Minji Lee; Claire Yee; Lauren Rogak; Eric Meek; Allison M. Deal; John Devin Peipert; Gita Thanarajasingam; Ethan Basch; Amylou C. Dueck
Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden

心理测量属性与PRO-CTCAE®平均综合分数作为症状性不良事件负担汇总指标的可解释性

Cancers 2025, Vol. 17, Page 3459
IF4.4
2025-10-290
OAAI
Minji K. Lee; Sandra A. Mitchell; Ethan Basch; Allison M. Deal; Blake T. Langlais; Gita Thanarajasingam; Brenda F. Ginos; Lauren Rogak; Tito R. Mendoza; Antonia V. Bennett; Brie N. Noble; Gina L. Mazza; Amylou C. Dueck
Methods for implementing and reporting the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events to measure patient-reported adverse events in cancer clinical trials

实施和报告不良事件常见术语标准（CTCAE）的患者报告结局（PRO）版的方法，用于测量癌症临床试验中的患者报告不良事件。

Cancer
IF5.1
2025-10-220
OAAI
Amylou C. Dueck PhD; Gita Thanarajasingam MD; Lauren Rogak MA; Gina L. Mazza PhD; Blake T. Langlais MS; Brie N. Noble MS; Brenda F. Ginos MS; Carolyn Mead-Harvey MS; Claire I. Yee PhD; Minji K. Lee PhD; Allison M. Deal MS; Eric A. Meek BA; Ethan Basch MD, MSc
Use of patient-reported outcomes version of the common terminology criteria for adverse events in oncology clinical trials

使用患者报告结局版不良事件通用术语标准在肿瘤学临床试验中的应用

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS
IF1.4
2025-09-011
OAAI
Rogak, Lauren; Forschmiedt, Jamie K.; Basch, Ethan; Mazza, Gina L.; Lee, Minji K.; Meek, Eric A.; Ginos, Brenda; Langlais, Blake T.; Noble, Brie N.; Deal, Allison M.; Yee, Claire; Thanarajasingam, Gita; Dueck, Amylou C.
Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial (vol 22, pg 1704, 2024)
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
IF5
2025-02-010
PRE
McBane Ii, Robert D.; Loprinzi, Charles L.; Zemla, Tyler; Tafur, Alfonso; Sanfilippo, Kristen; Liu, Jane Jijun; Garcia, David A.; Heun, James; Gundabolu, Krishna; Onitilo, Adedayo A.; Perepu, Usha; Drescher, Monic R.; Henkin, Stanislav; Houghton, Damon; Ashrani, Aneel; Billett, Henny; Mooberry, Micah J.; Mccue, Shaylene A.; Lee, Minji K.; Le-Rademacher, Jennifer G.; Wysokinski, Waldemar E.
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®)
QUALITY OF LIFE RESEARCH
IF2.7
2024-11-060
OAAI
Lee, Minji K.; Mitchell, Sandra A.; Basch, Ethan; Mazza, Gina L.; Langlais, Blake T.; Thanarajasingam, Gita; Ginos, Brenda F.; Rogak, Lauren; Meek, Eric A.; Jansen, Jennifer; Deal, Allison M.; Carr, Philip; Blinder, Victoria S.; Jonsson, Mattias; Mody, Gita N.; Mendoza, Tito R.; Bennett, Antonia V.; Schrag, Deborah; Dueck, Amylou C.
Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
IF5
2024-06-0111
PRE
McBane II, Robert D.; Loprinzi, Charles L.; Zemla, Tyler; Tafur, Alfonso; Sanfilippo, Kristen; Liu, Jane Jijun; Garcia, David A.; Heun, James; Gundabolu, Krishna; Onitilo, Adedayo A.; Perepu, Usha; Drescher, Monic R.; Henkin, Stanislav; Houghton, Damon; Ashrani, Aneel; Billett, Henny; McCue, Shaylene A.; Lee, Minji K.; Le-Rademacher, Jennifer G.; Wysokinski, Waldemar E.

研究方向

暂未获取到该数据
G
Gina L. Mazza
H 指数:25论文数:129被引数:2,655
A
Amylou C. Dueck
H 指数:76论文数:772被引数:2.6万
E
Ethan Basch
H 指数:95论文数:747被引数:4.9万
B
Brenda Ginos
H 指数:16论文数:87被引数:1,387
K
Kathleen J. Yost
H 指数:47论文数:260被引数:1.1万
G
Gita Thanarajasingam
H 指数:27论文数:177被引数:3,373
B
Blake Langlais
H 指数:13论文数:109被引数:690
A
Allison M. Deal
H 指数:63论文数:712被引数:1.9万
S
Sandra A. Mitchell
H 指数:60论文数:378被引数:1.9万
D
David T. Eton
H 指数:44论文数:113被引数:1.2万